final Flashcards
screening tests vs dx tests
screening: used to detect pathogens during sub-clinical stage
- from exposure to clinical signs
- early detection
- early treatment & ↑ prognosis
- focus: population level
dx: used to confirm or identify disease once clinical signs appear
- guide treatment & prognosis
focus: individual
measures of a test
validity: accuracy
reliability: repeatability
how do dx tests fx?
sense antibodies
false + vs false −
false positives can be caused by:
- similar disease agent ➞ confusion
- previous exposure
- lab/test error
- ensuring low false positives
- important for diseases w/ $$ tx or tx that cause suffering
false negatives can occur from:
- timing ➞ early in subclinical stage ➞ might not be long enough for immune system to begin response
- immunocompromised indiv don’t produce antibodies so tests cannot pickup
- ensuring low false negatives important for highly transmissible & severe diseases with extreme consequences
- ex: PRRS
proportion of the population diseased and exposed
proportion of the population exposed
proportion of the population diseased
true prevalence
actual level of disease prevalence in the pop
* cannot know ➞ estimate using AP
apparent prevalence
what prevalence appears to be based on the test
sensitivity
proportion of D+ that T+
* how accurate the test is at identifying diseased indiv
* ↑ Sn ➞ indiv that T+ are D+
specificity
proportion of D− that T−
* how good a test is at identifying non-diseased indiv
* ↑ Sp ➞ indiv that T− are D−
predictive value
probability of disease given the test result
positive predictive value (PPV)
probability/proportion of T+ that are D+
negative predictive value (NPV)
probability/proportion of T− that are D−
↑ prevalence =
↑ PPV & ↓ NPV
more dis in pop ➞ more indiv will T+ so less indiv will T−
↓ prevalence
↓ PPV & ↑ NPV
less dis in pop ➞ less indiv will T+ so more indiv will T−
AP < TP
underestimates TP of disease ➞ more false T− so D+ are missed
AP > TP
overestimates TP of disease ➞ more false T+ so D− animals are falsely dx
what measures do we use to quantify disease in populations?
- amount of dis
- morbidity: # of infxt - mortality: # of deaths from dis
- temporal distribution
- geographic/spatial distribution
- prevalence
- incidence
- cumulative incidence
- approximate incidence
prevalence
number of instances in a known pop at a specific point in time
* ** snapshot in time**
* diseases with long durations
* identifying common dis in pop
* evaluating control strategies
incidence
number of new cases in a known pop over a period of time
* preferred over prevalence
* dis w/ short durations
* understanding disease development and transmission (temporality)
* predicting risk of disease (change in health status)
cumulative incidence
proportion of non-dis animals at beginning of study that become dis during the study
* aka avg risk of developing disease during a time period
* who is getting diseased over time
* risk of disease
incidence rate
how quickly new cases develop over time
* closed pop only
closed populations
defined for entire study ➞ no additions or loses
* more control
* less bias
* dis-free animals at start = at risk
* preferred over open
open populations
animals enter/leave throughout duration of study
* hard to keep sample size ➞ difficult to track long term
* stable only if additions = withdrawals over time
* not as rigorous
* cannot calculate disease risk from open pop
study designs
descriptive: describes
* summarize & describe data
* no comparisons
* hypothesis generating
* frequency & distribution
* cannot make conclusions about associations btwn E & O
1. case report: rare or new conditions/dis involving 1-2 animals
2. case series: collection of an (4+) w/ same rare condition/dis
3. descriptive surveys: to estimate freq & percentages of diff variables, ex morbidity, mortality, management practices
analytical: compares
* comparisons between groups
* explore relationships & associations
* test hypotheses
1. experimental: control treatments & manipulate envir
2. observational: natural experiments
-no control over treatment or animals
-no manipulation of envir
-focused on exposures (E) & outcomes (O)
pig biology
- reach maturity at ~ 6 months of age, live up to 6-10 yrs
- litters 9-13 piglets (commercial breeds)
- similar biologically to humans
- simple/monogastric digestive system
- immune system
- organs - dry skin
pig behavior
- intelligent – easily trained, excellent hearing and sense of smell
- social animals – house in groups, have a social hierarchy
- behaviors
- running
- scratching
- swimming
- mud baths- no sweat glands ➞ sensitive to heat stress - thermoregulation - parasite control
pork production
- pork is the most consumed meat in the world
- US = 3rd largest producer/consumer of pig products, largest exporter of pig products
- production – mostly indoor confinement = highly controlled, reduced disease risk, but high density (therefore disease outbreaks a concern)
- US – 60,000 commercial pig farms
- 115 million pigs produced each year
pig operations
-
farrow-to-finish (all in one operation)
- breeding and farrowing sows - feed offspring to market weight – 280 lbs - 10-month cycle - expensive, labor intensive
-
farrow to feeder
- gestation to nursery phase - sold for finishing - reduced operations - more economic but less profit - less need for machines ➞ less cost investment
- **feeder to finish **
- finishing operation - reduced operations (don’t manage breeding stock) - lower labor requirements - more disease risks ➞ purchase from multiple farms, transportation, risk factors
coccidiosis in pigs: host
- commercial production & backyard pigs
- young piglets (farrowing >10d old)
- intestinal — damages G.I. tract
- subclinical on most farms
- sows don’t get sick ➞ sub-clinical
· carriers · bring into farrowing facility
- not all piglets exposed will get it
- must be a stressor: smaller, poor immune function more susceptible
coccidiosis in pigs: agent
- protozoa, genus Eimeria (many species)
- horizontal transmission: vehicle (feces) & fomites
- vertical transmission: mother to offspring
- pig-specific
coccidiosis in pigs: envir
- biosecurity:
· cleaning/disinfecting areas btwn litters · quarantine
- D+ piglets need warm, comfortable envir
· easy access to warm milk · supportive care
coccidiosis in pigs: clinical signs
- diarrhea @ 10d
- lethargic
- weight loss or no weight gain
- dehydration
coccidiosis in pigs: dx
- visual inspection of piglet’s clinical signs
- Necropsy - Visual inspection of the intestines (dead pig)
- cannot diagnostically test while alive
coccidiosis in pigs: tx
- anti-coccidial agents for piglets – poor efficacy, but may help if provided before GI tract damage
- antibacterial agents – not practical because of meat withdrawal period of many months
- production meat cannot contain antibiotics for a set # of mo - anti-coccidial disinfectants – clean between litters
- most effective
- easy access to milk, probiotics may help but unclear
streptococcus suey in pigs: host
- very common in both commercial & non
- more so in commercial ➞ confined indoor housing
- nursing & newly weaned
- worldwide
- found in all major producing facilities & countries - very prevalent in Asia - somewhat prevalent here
- zoonotic: common for butchers, farmers & vets to contract
- mature pigs not usually affected ➞ must have underlying stressor
streptococcus suey in pigs: agent
- bacterial pathogen streptococcus suey
- can be clinical or sub-clinical
- transmission:
- direct horizontal: nose to nose contact - direct vertical transmission - indirect horizontal: ➝ vehicles — fomites ➝ mechanical — flies & rodents
streptococcus suey in pigs: envir
- biosecurity protocols: disinfectants kill bacteria
- housing density
- reducing stressors
- aggression - ventilation - humidity & temp